Advanced Search
Contact | Corporate | Help

Daily news email for February 22, 2010 | Click here for updated news

BioSpace
Pinch Away the Pain: Scorpion Venom Could Be an Alternative to Morphine, Tel Aviv University Study

Simplified Darunavir Therapy Successful in Experienced Patients, Study

Peanut Allergies Tackled In Largest Ever Trial,

Genzyme Corporation in Icahn's Sights

Enzon Pharmaceuticals, Inc. CEO Resigns, Replaced by Executive Committee

BioSpace - Breaking News
BioCrossroads' Indiana Seed Fund Invests in Bioscience Vaccines, Inc.

Triathlon Medical Ventures, Affinity Capital Management Plan $10 Million Fund Biotech, Medical Device and Other Life-sciences Startups

Depomed, Inc. Comments on DM-1796 Pre-NDA Meeting and Horizant(R) Complete Response Letter

AMICAS, Inc. to Adjourn Special Meeting of Stockholders

Protein Sciences Corporation Announces as New CEO

Biotech News - Business Wire
Anoxomat Anaerobic System Offers Clinical Laboratories Green Advantages Over Gas-Bag Methods That Generate Hazardous Waste

Picis to Feature Hospital Executives in Panel Discussions at HIMSS10 Annual Conference

Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Bus Tour

Memometal Technologies Acquires OrthoGlide Ankle Technology From Advanced Bio-Surfaces, Inc.

Life Technologies Announces Completion of $1.5 Billion Senior Notes Offering
Biotech News - PR Newswire
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis

FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease

Grace to Feature New REVELERIS(R) System at Major Industry Event in Asia

Fortrex Technologies Achieves HITRUST Common Security Framework Assessor Status

Certain Senesco Insiders Purchase Senesco Securities Held by Stanford Venture Capital Holdings

 Biotechnology - Moreover
Novavax reports positive results from influenza vaccine study

United Therapeutics withdraws European MAA for hypertension drug

JPMorgan Starts Dendreon (DNDN) at Overweight $48 Tgt

Protein Chemist - Biotechnology

Biotech convention features world's largest partnering event

 CenterWatch - Clinical Trials
ResearchPoint Global Continues to Grow, Add CRO Partners

German CRO Clinicalprojects Plans to Open First Foreign Office

Chiltern Opens Office in Argentina

Biologics to Manage Cancer Study for National Marrow Donor Program

BBK Worldwide Opens First West Coast Office
Clinical Trials - Business Wire
Atrium Medisch Centrum Parkstad en GI Dynamics starten klinisch onderzoek EndoBarrier Gastrointestinal Liner voor de behandeling van diabetes type 2

Nature Publishing Group Partners with Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine

Carolinas Medical Center NorthEast Selects Premier Healthcare Alliance Quality Improvement Solution to Improve Patient Care, Reduce Costs

Data Presented at International Haemovigilance Seminar Confirm Safety of Cerus' INTERCEPT Blood System for Platelets and Plasma

iMDsoft and iSOFT Announce Distribution Agreement

 Clinical Trials - PR Newswire
Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains

Watson Files FDA Application for Generic Aplenzin(TM) ER

NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland

Novartis Drug Tasigna(R) Receives FDA Priority Review for Newly Diagnosed Patients With Early-Stage Chronic Myeloid Leukemia

Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery

 Contract Pharma
Recipharm Acquires Cobra Biomanufacturing

Novartis’ Menveo Vaccine Gains Approval

BioStorage Gains Green Certification

Pharmatek Gains DEA Approval for Controlled Substances

PPD Opens Offices in Philippines and India
FDA Drugs- What's New
Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between July - September 2009

Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between January - March 2008

Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between April - June 2008

Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between October - December 2008

Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between January - March 2009

 FDA News - Business Wire
PositiveID Corporation Successfully Completes Phase I Development of its Rapid Virus Detection System

Enzon Board of Directors Appoints Executive Committee

Genzyme Receives Notice of Icahn Partners Nomination of Directors

Physio-Control Resumes Unrestricted Global Shipments of Its LIFEPAK® Defibrillators

Hotze Enterprises Opposes United States Senate Bill That Threatens Americans Rights to Nutritional Supplements

 FDA Press Releases
U.S. Attorney New Release: Miami Prescription Drug Diverter Sentenced To 70 Months In Prison

U.S. Attorney New Release: SK Foods former owner charged with RICO violations

FDA Cancer Drug Approval Rate Highlighted in JNCI

FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma

FDA Warns about Serious Side Effects from Maalox Product Mix-Ups
FDA Vaccines, Blood and Biologics - What's New
Biologic Product Shortages

Cord Blood Licensure: A Workshop

Field Correction of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal Expiration Dating

COBAS TaqScreen MPX Test

Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal Questions and Answers

 FierceBiotech
BioSante gets good news on LibiGel

Was Rigel's $1.2B RA deal over-hyped

The hunt is on for next Biogen CEO

Novartis gets Menveo vaccine approval

Report: Icahn to launch bid for Genzyme control

 FierceBiotech IT
Cite competitive plus to justify informatics

Mitigate risks in clinical trials

Reg system targets data, user issues

Marketing, multimedia aid recruitment

Cyber-attacks target pharma
FierceBiotech Research
Research team unveils new potential for drugs

Bonding hormone may help treat autism

Cystic fibrosis team discovers new research path

Researchers find a cheap tool for controlling HIV

Paul Nurse outlines ambitious agenda for research complex

 FiercePharma
Reports spark new debate over Avandia

Generic-drug approvals languish at FDA

Which drugs gets the most-expensive crown

Taro to shutter Irish manufacturing facility

One-fourth of new scrips go unfilled

 FiercePharma Manufacturing
Russia taps nanotech for drug production

Virtual GMP consulting makes timely debut

Trade group goes electronic with manufacturing guides

REMS on the rise

Protalix pits plants vs. mammals in sexy bet
FierceVaccines
Peptide could be clue for cancer vax

Study: No hard evidence that flu vaccine protects the elderly

Novartis VC arm backs fledgling universal flu vax

Dehydration process could eliminate the vax cold chain

WHO to update its pandemic alert

 GEN News Highlights
ReNeuron Raises £4.7M to Fund Phase I Study with Stem Cell Therapy for Ischemic Stroke

FDA Sanctions Novartis Vaccine for Meningococcal Disease in Adolescents and Adults

Novartis to Evaluate NasVax Adjuvant Technology

Researchers Uncover Potential Gene Target for Lone Atrial Fibrillation

Genentech and UCSF's Small Molecule Discovery Center Ink Deal Targeting Neurodegenerative Diseases

 Health News - BizJournals.com
Jewish Hospital Foundation has record year in 09

Biotechs proceed with social-media caution

Hologic settles suits, to pay $12.5M

GTC connects on $7M from French partner

Ethicon Endo-Surgery, Hologic settle patent dispute
Health News - CNBC
Obama Health Plan Would Cover 31 Million Uninsured

Tony Fratto: Instead of Fixing Health Insurance Markets, Obama Plans to Fix Prices

Enzon CEO resigns, replaced by executive committee

Glaxo falls most on FTSE after US Senate's warning on diabetes drug Avandia

Stocks Remain Flat; Focus on Fed, Greece

 Health News - Fox Business
Obama Offers Detailed Health Plan Before Summit

Drug Stocks Rise Nominally; Glaxo Slides

Early-Market Movers: Smith International, Campbell Soup

Icahn To Nominate Four To Genzyme's Board

Obama Has Insurers in Sight as he Sets Health Plan

 Marketwire - Pharma and Biotech
Histostem Participates in Clinical Trials Demonstrating the Effective Use of Its Proprietary Stem Cells in the Treatment of Cirrhosis of the Liver

Singularity University Announces 2010 Graduate Summer Program

Ceragenix and BexPharm Enter Into Distribution and Supply Agreement for EpiCeram(R)

Proteonomix, Inc. (PROT) Announces That Michael Cohen, Its President, Was Interviewed on a Medical Television Show Broadcast Throughout Central and South America

BioSante's (Nasdaq: BPAX) CEO Pleased With the Progress of LibiGel(R) Phase III Clinical Development Program
MassBio News
MassBio Thanks Millennium for Making Progress Toward Winning the War on Cancer

Check out the NEW & IMPROVED W.B. Mason contract for MORE SAVINGS!

MassBio and American Cancer Society present Symposium on Progress Toward Winning the War on Cancer

Policy makers, industry leaders gather to cement commitment to life sciences industry

Massachusetts Life Sciences Center Announces 2010 Internship Challenge Program

Medical Pharma - PR Newswire
Star Scientific Files Application with FDA for Ariva-BDL(TM) Approval as First Modified Risk Tobacco Product

Sunridge International to Present to the Long Island Investment Banking Group

PRA International Names Project Management VP for the Americas

Oncure Medical Corp. Names Duane Choate President & Chief Executive Officer

KATSI's MedAZ Healthcare Software Earns Surescripts(R) Certification

 National Center for Biotechnology Information
Bookshelf News

dbVar News and Announcements

Genome Reference Consortium News

HomoloGene News

Library-LinkOut Announcements
Nature Biotechnology
Industry gains on moneyback schemes

$2 million rice verdict against Bayer

Biorefineries' stimulus win

Purpose-built chromosome

FDA balks on MedImmune's cell-grown flu vaccine

 New York Times- Biotechnology
After a Shooting, Colleagues Try to Regain Footing

Staggered by a Shooting, a Small Biology Department Tries to Regain Its Footing

A Previous Death at the Hand of Alabama Suspect

A Previous Shooting Death at the Hand of Alabama Suspect

A Previous Shooting Death at the Hands of Alabama Suspect

 New York Times- Pharmaceuticals
A Protein That Fuels Cancer, and a Drug to Fight It

A Roller Coaster Chase for a Cure

Generics Face Longer Wait for Approval

Howard Lotsof Dies at 66; Saw Drug Cure in a Plant

Howard Lotsof Dies at 66; Found Drug Treatment in an African Plant
OnBioVC
PhaseBio Pharmaceuticals, Inc.: Series B $25M

CeQur Ltd.: Series A $29.6M

HistoSonics, Inc.: Series A $11M

Acton Pharmaceuticals, Inc.: Series A $15M

CircuLite, Inc.: Series C $32.5M

 Outsourcing-Pharma
Informex companies hope for a brighter 2010

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

Trial sponsors and CROs must do more to recruit older people, says EU group

Intelligent packaging can cut cost of trials; Stora Enso

MENA emerging as trial destination says ClinTec CEO

 Pharma News - Business Wire
Somerset Hospital to Automate Medication Dispensing with McKesson

Research and Markets: Advances in Molecular Imaging - Companies and Technologies that are Driving Change

CORRECTING and REPLACING GTC Enters into Agreement to Receive $7 Million in Financing from LFB

Cannabis Science Inc. Announces Advances In Its Analytical Lab Logistics

MedTera President David Duplay Joins Advisory Board for HealthPrize Technologies
Pharma News - PharmiWeb
SOCIETY REACTS TO HOUSE OF COMMONS SCIENCE AND TECHNOLOGY COMMITTEE REPORT INTO HOMEOPATHIC PRODUCTS

RNIB appoints Doctors.net.uk for GP education campaign

Retacrit to be the 1st biosimilar epoetin to achieve subcutaneous licence in renal patients

Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools

US FDA approves Rituxan/MabThera for the most common type of adult leukemia

 Pharma News - PR Newswire
Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks

Curemark CM-AT Autism Treatment Granted FDA Fast Track Status

Samplify Systems Next-Generation Prism 3.0 Real-Time Compression IP Named Finalist in EDN Magazine's 20th Annual Innovation Awards

ConvaTec Introduces Flexi-Seal(R)(TM) SIGNAL(TM) FMS

CIPA Named Google's Canadian Online Pharmacy Verifier

 Pharmaceutical - Moreover
Labopharm raises USD20.9m in public offering after underwriters exercise over-allotment option

Quality Control Technician - Pharmaceuticals

REGULATORY CMC MANAGER- SWITZERLAND

Reproducible Production Scale Freeze Drying Available From SP Industries

RNCOS: South Africa Pharmaceutical industry to Grow 22% by 2013
PR Leap - Biotech
Vivante GMP Solutions Enters into License Agreements with Crucell

Ascent Scientific Licenses Novel Columbia University Technology for High-Resolution Optical Imaging of Synaptic Activity in the Brain

World First - Green Cell Technologies' Extraction Process reduces plant & micro-organisms to a stabilised molecular level

SourceSolution Announced Today the Launch of New Website Features Designed to Support Biotechnology and Pharmaceutical Strategic Sourcing Decisions

New Vice President of Production Joins Vivante GMP Solutions' Team

 PRWeb - Biotechnology
Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer

TheDigitalPathologyWiki.com A New Resource For Digital Pathology

BioDiscovery Releases a Unique New Global Repository for Genomic Variation Data

Chinese Biopharaceutical Association Hosts 2010 Chinese New Year Gala in Washington, DC

Photometrics® to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting

 PRWeb - Pharmaceuticals
Smiley & Smiley Files Lawsuit Alleging Tamiflu Caused Boy to Jump from Second Story Window

OpenQ Announces its Participation at CBI’s 2nd Annual Bio/Pharmaceutical and Medical Device Forum on Speaker Program Management

Healthcare Packaging Expands Annual Conference Program and Moves to New Venue in Princeton, NJ

Greenberg Traurig Client Home Diagnostics Enters into Merger Agreement with Nipro Corporation

Pollen.com Launches Features to Customize Allergy Information - Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms
Scientific American
Same Species, Polar Opposites: The Mystery of Identical Creatures Found in both Arctic and Antarctic Waters [Slide Show]

No Sex Needed: All-Female Lizard Species Cross Their Chromosomes to Make Babies

Kepler Spacecraft May Be Able to Spot Elusive Oort Cloud Objects

Germany Floats New Plans to Keep Hydrogen-Powered Cars in the World's Transportation Mix

In a Hurry New Battery Recharging System Promises Quicker Turnaround for Plug-In Hybrid Vehicles

 Xconomy Life Sciences
NIH Chief Stresses Economic Impact of Federal Biomedical Funding

Icahn Making His Move On Genzyme

Rival Buyout Offer for Amicas

Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist

Sepracor CEO Resigns

 Yahoo Biotech News
US scientists warn of fraud of stem cell 'banks' (AFP)

Gene Therapy Shows Promise Against HIV (HealthDay)

U.S. "tweaks" stem cell policy (Reuters)

Long-Distance Runners May Have Endurance in Their Genes (HealthDay)

Stem cell experiment reverses aging in rare disease (Reuters)


SourceSolution © 2008-2010